The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
–
Dr. John Pandolfino, Chief of Gastroenterology and Hepatology and Director of the Northwestern Medicine Digestive Health Institute, joins John Landecker to discuss a new technology Northwestern has been working on and developing that could allow doctors to make a “digital twin” of your body part to help with treatment.
–
An outbreak aboard a cruise ship of a rare rodent-borne illness called hantavirus has left three passengers dead and sickened others, with health authorities across four continents trying to track down and monitor passengers who disembarked the ship before its deadly outbreak was detected.
Dr. Michael Angarone with Northwestern Medicine said it’s not likely the outbreak will become the next pandemic. “We’ve never had a documented hantavirus case in the rats here in Chicago. Most of the hantaviruses that we see here in North America is actually west of the Mississippi,” he said.
–
A Chicago woman noticed something was off with her body and took action. Doctors say it saved her life. Carol Smeja was losing weight. She was confused and tired. It was disrupting her daily routine. Despite having no risk factors, she was later diagnosed with esophageal cancer. It’s a rare, but deadly disease and often has no symptoms at all.
Carol joined ABC7 along with doctor Sri Komanduri an Interventional endoscopist with Northwestern Medicine, to talk about esophageal cancer.
–
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about what we should know about the hantavirus outbreak on a cruise ship, and a new study that showed that an active ingredient found in popular weight-loss drugs may also help reduce alcohol use.
–
Dr. Sterling Elliott, clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School of Medicine, joins Lisa Dent to discuss her experience with and diagnosis of Benign Paroxysmal Positional Vertigo (BPPV).
And, as always, he answers health questions from listeners.
–
Dr. Murad Alam, Vice-Chair of Dermatology at Northwestern University’s Feinberg School of Medicine; Professor of Dermatology, Otolaryngology, and Surgery and president of the American Academy of Dermatology (AAD), joins Lisa Dent to talk about Melanoma.
Dr. Alam shares how people can self-check for any suspicious skin markings and take preventative measures to protect themselves.
–
Dr. Sri Komanduri, Director of System Integration for the Digestive Health Institute at Northwestern Medicine, joins Wendy Snyder for this week’s health update.
Dr. Komanduri talks about the new Center for Advanced Endoscopy at Northwestern Medicine Central DuPage Hospital, how endoscopy and colonoscopy are vital for early cancer detection, and shares some new minimally invasive treatments for conditions like GERD, Barrett’s esophagus, and GI lesions.
–
Pulmonologist Dr. Ravi Kalhan, MD answers the internet’s burning questions about our lungs.
Why do we yawn and why is it contagious? How do lungs heal after a smoker quits? What chemicals actually make vaping dangerous? How does a lung transplant work? Answers to these questions and many more await on Lung Support.
–
Lipedema was first formally described at the Mayo Clinic in 1940, then named and clinically documented a decade later. Yet, despite occurring in an estimated 10% of women, lipedema is not well understood by doctors.
“There are very few physicians that are able to diagnose lipedema,” says Dr Guillermo Oliver, director of the center for vascular and developmental biology at Northwestern University.
–
Essential tremor impacts 7 million Americans who navigate their condition without a targeted treatment. Finally, that’s about to change. Research presented at the American Academy of Neurology’s annual meeting sparked excitement for the first time: a targeted therapy for essential tremor.
Movement disorders specialist Dr. Neil Shetty says the new drug is generating significant excitement because it’s designed for essential tremor.